Clinical Trials Directory

EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer

A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)

Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment

SAbR For Oligometastatic Renal Cell Carcinoma

A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer

Stereotactic Body Radiation Therapy for Breast Cancer

Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma

Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas

X-linked Hypophosphatemia Disease Monitoring Program

Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

Control of Myopia Using Novel Spectacle Lens Designs

The ESTxENDS Trial- Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation-extension of Follow-up

Non-contrast DWI for Supplemental Screening

Registry in Patients With Aorto-iliac or Iliac Aneurysms

Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer

A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy

Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis

CyberKnife Dose Escalation Prostate Cancer Trial

This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)

Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma

Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1

Development of Adaptive Deep Brain Stimulation for OCD (Phase 1a)

Explore Transplant @Home Within Kaiser Permanente Southern California

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy

DOTATOC PET/CT for Imaging NET Patients

Investigating the Direct Superior Approach for Total Hip Arthroplasty as an Effective Alternative to Traditional Posterior Approach

PREPA PREvention of Loss of Autonomy

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

OFSEP High Definition Cohort

Atovaquone (Mepron®) Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML)

Prevention of Allergic Diseases in Infants

AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma

Clinical and Fundamental Aspects of Prosthetics and Translocation of Mitral Valve Chordae

Neural Mechanisms of Decision Making in Hoarding Disorder

Filipino Family Health Initiative

AGRA Before and After Liver Transplantation

Comprehensive Study of Post-surgical Pain After Pectus or Spine Surgery

A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

ERG Components in Schizophrenia and Bipolar Disorder Type I

Breast Cancer Screening: Digital Breast Tomosynthesis Versus Digital 2D Mammography

Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)

Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery

A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation